Home | My NASDAQ | Tools | Mobile | Company List | ETFs | Pre-Market Quotes Real-Time Quotes After Hours Quotes
Home > Quotes > ONXX > Company News
ONXX
ONXX
$46.8
*
0.39
negative
0.84%

*Data as of May 25, 2012   | ONYX Pharmaceuticals, Inc. | Industry: Health Care | HQ: California, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 |  Sponsored

ONXX News Headlines

Share |


   


Onyx/Bayer's Nexavar Disappoints - Analyst Blog
5/23/2012 4:44:44 PM - Zacks.com

Onyx Says Bayer Submit NDA For Regorafenib To Treat Metastatic Colorectal Cancer
5/23/2012 1:01:00 PM - RTT News

Stocks Remain Higher at Midday on Housing Data and EU Hopes Ahead of Summit
5/22/2012 1:33:00 PM - Knobias

European Markets Extended Their Gains Ahead Of EU Summit
5/22/2012 12:03:00 PM - RTT News

Stocks Rise Early on Increase in April Existing Home Sales
5/22/2012 10:39:00 AM - Knobias

Futures Point to Flat Open; Facebook Falls Further in Premarket
5/22/2012 9:17:00 AM - Knobias

Stock Futures Point Higher Before Housing Report
5/22/2012 8:28:00 AM - TheStreet

Futures Up in Premarket Despite Fitch Downgrade of Japan
5/22/2012 8:16:00 AM - Knobias

Stocks to Watch: Dell, Williams-Sonoma (Update 1)
5/22/2012 7:44:00 AM - TheStreet

European Markets Rise; Miners, Carmakers Higher
5/22/2012 7:41:00 AM - RTT News

German Market Moderately Up
5/22/2012 7:19:00 AM - RTT News

5 Things You Should Know Before the Stock Market Opens
5/22/2012 6:04:00 AM - TheStreet

Bayer's Nexavar Fails To Meet Goals In Lung Cancer Study
5/22/2012 5:06:00 AM - RTT News

Bayer: Nexavar Lung Cancer Phase III Study Misses Primary Endpoint
5/22/2012 3:16:00 AM - Dow Jones Business News

Bayer's Nexavar Fails In Non-Small Cell Lung Cancer Trial - Quick Facts
5/22/2012 2:50:00 AM - RTT News

Outlooks for Pfizer, Arena and Onyx Following Busy May
5/21/2012 7:02:00 AM - TheStreet

Biotech Stock Live Chat: ASCO & Obesity
5/17/2012 11:55:00 AM - TheStreet

ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)
5/17/2012 6:19:00 AM - TheStreet

Disappointing Data on Pfizer Drug - Analyst Blog
5/16/2012 5:07:01 PM - Zacks.com

Onyx Pharmaceuticals To Present At B Of A Conference; Webcast At 11:00 AM
5/16/2012 10:03:00 AM - RTT News

FDA Panel to Review Onyx Drug - Analyst Blog
5/7/2012 5:14:01 PM - Zacks.com

Onyx Pharma To Present At Deutsche Bank Conference; Webcast At 9:20 AM ET
5/7/2012 8:19:00 AM - RTT News

Higher Expenses Hurt Onyx' Earnings - Analyst Blog
5/3/2012 9:48:57 AM - Zacks.com

Futures Point to Modestly Higher Open Following Economic Data
5/3/2012 9:19:00 AM - Knobias

Onyx Pharma Loss Widens In Q1
5/2/2012 8:08:00 PM - RTT News